Andrew Hanson, right, will speak Friday, April 14 in Bond LSC’s Monsanto Auditorium as the 2017 Dr. Charles W Gehrke speaker. | Photo by University of Florida, Institute of Food and Agricultural Sciences
People often think of metabolism as a perfect network. But that assumption is simply not accurate.
Andrew Hanson, an eminent scholar and professor at the University of Florida, describes the misunderstanding as “the power of a paradigm.” American biochemist Albert Lehninger spread the misunderstanding in his classic textbook “Biochemistry”, in which the message he communicated to generations of students was: metabolism is a beautiful machine that functions flawlessly.
Hanson challenges this “metabolism is perfect” paradigm using illustrations from different kinds of organisms in his lecture. He will speak in Bond LSC’s Monsanto Auditorium at 1 p.m. Friday April 14, during the 33rd annual Missouri Life Sciences Week.
For every living organism, metabolism is the sum of every chemical reaction that occurs to maintain life. This sum contains all the metabolites — small molecules created at each level of cell processes and final products — that share a part in the growth, development, reproduction and running of cells and whole organisms.
However, enzymes can make mistakes; many chemical compounds in cells are unstable and undergo spontaneous reactions. The consequences of enzyme errors and chemical side-reactions are, at best, unwanted and sometimes toxic, so organisms have developed mechanisms – damage-control systems – to deal with the consequences of damage.
Hanson’s lab has studied metabolite damage and the damage-control systems that plants and microorganisms employ to cope. But the impact of metabolic problems also reaches into the human domain, causing disease from failure or mutation of damage repair enzymes. “It matters in aging humans and animals a great deal, because aging is the result of cumulative damage,” Hanson said.
Plants are also afflicted by metabolite damage. Under environmental stress such as high temperature or water loss, the error rate of enzymes and rates of unwanted chemical reactions can go up.
The understanding of metabolite damage could also advance metabolic engineering, which is a purposeful manipulation by combining metabolic pathways and DNA techniques to produce desired products. After creating new pathways in an organism, it may fail to cope with the abnormal reactions produced by the new pathways. To fix the problem, the only solution might be to install the required damage control enzymes.
Hanson’s lab hopes to identify new or unsuspected damage reactions, and enzymes that repair or prevent damage. They also are working to connect with metabolic engineering groups that install modified pathways in plants and microbes to study sources of damage and propose solutions.
Metabolism is not perfect. However, after studying its imperfection for years, Hanson concluded, “life is put together in a very beautiful and even more powerful way than we first realize. It makes a lot of mistakes, but it also fixes them so well that we do not even notice them.”
Hanson’s lecture on “Fixing or safely trashing broken metabolites and why it matters” is this year’s Charles W. Gehrke distinguished lecture. Gehrke, a longtime MU professor of Biochemistry, was selected by NASA to analyze rocks retrieved from the first moon landing for any traces of extraterrestrial life. He died in 2009.
Hanson’s lecture is free and open to the public as part of Missouri Life Sciences Week. It occurs at 1:00 on Friday, April 14 in Bond LSC’s Monsanto Auditorium. See more about events during the week at bondlsc.missouri.edu/life-sciences-week.
Mahmoud Khalafalla, a Ph.D. student at Weisman’s lab, is isolating RNA from salivary glands of Sjögren’s syndrome mouse model to look for the expression of pro-inflammatory genes. | photo by Jinghong Chen, Bond LSC
By Jinghong Chen | Bond Life Sciences Center
Our immune system is often the key to our health. Everyday, it works to protect us from foreign invaders such as bacteria and virus, but what happens when it attacks our own tissues?
Gary Weisman, a Curator’s Distinguished Professor of Biochemistry at the Bond Life Sciences Center, is working to advance our understanding of the mechanisms behind immune system function and autoimmune diseases such as Sjögren’s syndrome.
In our immune system, B cells are responsible for producing antibodies to recognize foreign invaders. However, in many autoimmune diseases, B cells produce autoantibodies that recognize our own proteins, causing inflammation and tissue damage. In Sjögren’s syndrome (SS), they attack the glands that produce saliva and tears.
Patients with SS often suffer chronic dry eyes and dry mouth, which might lead to bacterial infection, difficulties in swallowing and speech.
“The symptoms decrease the quality of life rather than the length of life,” said Lucas Woods, research lab manager in Weisman’s lab.
Although SS patients are at higher risk of developing lymphoma cancers and other concurrent autoimmune diseases that may increase mortality, Woods further explained.
According to the Sjögren’s Syndrome Foundation, there are an estimated four million people living with the disease in the U.S. For unknown reasons, 90 percent of them are female.
Yet, current clinical treatments only reduce symptoms by using artificial saliva and tears or cholinergic agents to promote fluid secretion, but there is no approved treatment to reduce the inflammation of the glands themselves. This is the focus of Weisman’s lab.
Sensor of danger
There are 15 different types of nucleotide receptors in humans that regulate numerous cell processes from inflammatory responses to tissue regeneration. Those receptors are stimulated by nucleotides such as ATP. In the past three and a half years, Mahmoud Khalafalla, a Ph.D. student in Weisman’s lab, has focused on one of them in particular – the P2X7 receptor.
Previous studies show increased P2X7 expression in salivary glands from SS patients, as compared to healthy individuals. To understand the reasons behind this, Weisman’s lab used genetically modified mice that develop disease traits similar to SS patients.
In this mouse model, Sjögren’s-like disease occurs when the immune cells invade salivary glands and damage the tissue, leading to decreased saliva production. The invasion of immune cells is triggered by proinflammatory cytokines, a type of signaling molecule that promotes the recruitment of immune cells to the inflamed areas.
But what induces those cytokines?
Weisman’s lab tries to piece together the answer. For the first time, they found that the P2X7 receptor is responsible for the release of these proinflammatory molecules from salivary gland epithelial cells.
To function, most cell-surface receptors require ligands that bind to the receptor to induce cellular responses. The ligand for the P2X7 receptor is ATP – the “energy currency inside of cells.” P2X7 receptors are activated when high concentrations of ATP are released to the outside of the cells, which typically occurs when the cells are injured during inflammation.
“P2X7 receptors [act like] the sensor of danger,” Khalafalla said.
After identifying the role of the P2X7 receptor, the lab then asked: if we stop its activation, what would happen?
Using a drug that inhibits P2X7 receptor activation, they blocked the receptor in their SS mouse model to determine its effect on the development of autoimmune disease. Interestingly, saliva secretion was restored when the P2X7 receptor is blocked while the levels of invading immune cells in salivary glands were dramatically reduced.
“This gives us the thought that [blockade of the] P2X7 receptor is really a promising strategy to reduce salivary inflammation. This may not only relate to Sjögren’s syndrome, but to other autoimmune diseases as well,” Khalafalla said.
Our receptor
Another similar receptor that plays a role in autoimmune diseases is the P2Y2 receptor, which has been referred to as “our receptor” by Weisman’s lab.
As one of the researchers who proved the existence of this receptor, Weisman has spent most of his career studying it.
One of his research projects investigating P2Y2 receptors in human disease recently gained a grant extension for another five years from the National Institutes of Health. The lab found that in a mouse model of SS, similar to the P2X7 receptor, the expression of P2Y2 receptors was increased in both the salivary gland epithelial cells and immune cells.
Furthermore, after they knocked out the P2Y2 receptor in the SS mouse model by breeding them with genetically-modified P2Y2 receptor knockout mice, the inflammation of salivary glands was dramatically reduced.
“The very next step is that we are going to isolate these immune cells out of the diseased mouse salivary glands, and characterize what kinds of cells they are. We want to know exactly which ones are controlling the development of autoimmune diseases, and how P2Y2 receptors and nucleotides like ATP in general are contributing to the diseases,” Woods said.
Gary Weisman is a Curator’s Distinguished Professor of Biochemistry at the Bond Life Sciences Center. His research focuses on the relationship between inflammatory diseases and nucleotide receptors. He currently works on a collaborative research project with Dr. Carisa Petris, an eye surgeon at the MU Hospital, to understand the mechanism of how Sjögren’s syndrome damages the tear-secreting lacrimal glands in mice.
Marc Johnson, a virology professor at Bond LSC. | photo by Mary Jane Rogers, Bond LSC
By Mary Jane Rogers | Bond LSC
“#IAmScience because the mysteries of the natural world aren’t going to solve themselves.”
Since the third grade, Marc Johnson never wanted to be anything else but a mad scientist. What began as experimenting with sprouting seeds and chemistry sets has blossomed into a career in virology. Specifically, he studies the “moves and countermoves” of viral components, a few hundred thousand at time! His advice for people wondering if science is for them: “If you’ve ever stayed up until 4 in the morning to finish a puzzle, you might be a scientist.”
Jessica Whited studies the genetics behind how salamanders grow severed limbs
By Eleanor Hasenbeck | Bond LSC
An axolotl rests at the bottom of its tank at Menagerie du Jardin des Plantes in Paris. | photo by Jack Baker, Flickr
It takes about two months for an axolotl to regenerate a lost limb. Humans, as you probably know, don’t regenerate limbs.
But, a basic understanding of how the Mexican salamander regrows limbs advance regenerative medicine in humans according to Jessica Whited, a researcher at Brigham Women’s Hospital and assistant professor at Harvard Medical School.
Whited will speak at 3:30 p.m., Thursday April 13, in Monsanto Auditorium as part of Missouri Life Sciences Week at Bond Life Science Center. Her lecture, “Identifying roadblocks to regeneration in axolotl salamanders” will present the lab’s discoveries and evidence that a specific gene in axolotls can block the animal’s ability to regenerate.
Whited’s lab found axolotls can exhaust their ability to regenerate. When a limb is severed repeatedly, the salamander stops producing blastemas, the mass of cells capable of regeneration that allow the limb to grow back. This could be due to a dysregulated gene blocking the animal’s ability to produce them.
The Whited Lab sequenced the mRNA in axolotls that could regenerate limbs and that could no longer regenerate. They found 912 genes that differed between the two groups. Whited will discuss one of these genes, which her lab considers a potential inhibitor to regeneration.
“It’s much more common for people to think “Oh, what are the things that promote limb regeneration?’ than it is to think about the things that we might have to block to make it happen,” Whited said. “This project has the potential to uncover the roadblocks, which could turn out to be equally critical.”
An MU alumna, Whited received the National Institutes of Health New Innovator Award in 2015 for her work with this unique regenerative salamander. She earned a PhD in biology at the Massachusetts Institute of Technology, and two undergraduate degrees in biological sciences and philosophy at MU.
Whited attended MU as a Bright Flight and Curator’s Scholar. And though it happened nearly 20 years ago, she said receiving those two scholarships were among the most important things that happened in her career. As a high school student, she knew she would go to college, but financially, she didn’t know how it would happen. She also credits her education and undergraduate research experience at MU for preparing her to think at the research bench.
“You have to get an undergraduate education, and it totally prepared me even for graduate school at MIT, which is one of the top programs in the world, in many subjects, but in biology especially,” Whited said. “The idea that you could find a career where you’re using your brain as your primary asset, I figured that out while I was at the University of Missouri, because there were people, our professors, doing that.”
Whited’s lecture is free and open to the public as part of Missouri Life Sciences Week. It occurs at 3:30 on Thursday, April 13 in Bond LSC’s Monsanto Auditorium. See more about events during the week at bondlsc.missouri.edu/life-sciences-week.
Plants on the left grow with rhizobia bacteria, one type of fixing nitrogen bacteria, in the greenhouse, while the plants on the right grow without the bacteria. | photo by Jinghong Chen, Bond LSC
Jinghong Chen | Bond Life Sciences Center
Since eight years old, Beverly Agtuca knew she wanted to be a scientist.
A trip to Philippines changed Agtuca, an American-born Filipino, and inspired her passion on plants.
“My grandma always told me to work in the field all day so that they can have enough food for us to eat,” Agtuca said. “The life [in Philippines] is so different from here…I want to not just provide food but be that scientist trying to figuring something out, and hopefully saving the world.”
Agtuca is on her way to her dream. She is now a third year doctoral student in Gary Stacey’s lab at Bond Life Sciences Center with a focus on nitrogen-fixing bacteria.
Although she has been involved in research since high school, Agtuca recently faced a new challenge of telling people about her work. The Preparing Tomorrow’s Leaders of Science class tasked her with making a 90-second video to explain her two-year study to the general public.
Her team, “The A Team,” chose to go with the benefits of having nitrogen-fixing bacteria.
For decades, people have been adding nitrogen fertilizers to plants to improve yields, but this can lead to pollution in water systems and ecosystems. Scientists need to enhance plant productivity to meet a huge food demand by the year of 2050.
One little bacteria might make this possible and save the world. Rhizobia, a type of natural bacteria in soil, are able to fix nitrogen via biological nitrogen fixation. These bacteria can convert nitrogen gas into ammonia as a plant nutrient source, while the plants give all the carbon sources back to the bacteria.
“It is like a walky-talky,” Agtuca said. “They are communicating with each other.”
Yet before speaking to the public, Agtuca needs to explain the plant-bacteria interaction to her teammates. Students less well versed in science like Jessica Kaiser, a strategic communication student, thinks of science differently.
“The biggest issue we ran into is jargon, like basic science words that [my teammates] are so comfortable with,” Kaiser said. “We need to focus on what people care about instead of the technical sides, to focus on why it matters to anybody rather than just to a science person.”
Within two weeks, they produced the video “Good Microbes: reducing pollution one farm at a time.” Along with two other teams, their videos will be commented and judged by representatives from Monsanto.
“The A Team” stands together at Bond Life Sciences Center. From left to right: Jessica Kaiser, Sven Nelson, Anna Glowinski, Eleni Galata and Beverly Agtuca. | photo by Jinghong Chen, Bond LSC
The 90-second video is just a glimpse of Agtuca’s study. In the last two years she has been focusing on the use of a new technique — laser ablation electrospray ionization mass spectrometry (LAESI-MS) — that does in situ metabolic profiling of tissues. The lab is using LAESI-MS to investigate the metabolites in a well-characterized model plant-rhizobium system, specifically nitrogen-fixing soybean nodules resulting from root infection by the symbiotic bacterium Bradyrhizobium japonicum.
This work includes a huge collaboration that was developed through a Department of Energy (DOE) grant involving the George Washington University, Washington D.C. and the Environmental Molecular Science Laboratory (EMSL), Pacific Northwest National Laboratory, Richland, WA.
LAESI-MS works like a superhero’s laser-like beams. You first aim the laser on the sample, which then heats it and causes neutral particles to be released into the air. This plume of neutrals is then captured and ionized by the electrospray, and finally analyzed by the spectrometer to figure out the exactly what metabolites in nodules are involved in biological nitrogen fixation.
“It takes about three seconds to analyze one sample using this LAESI-MS technique,” Agtuca said. Other metabolic techniques require extensive pre-treatment of the sample before analysis.
By analyzing the data collected via LAESI-MS, the lab is able to confirm that future plant studies could apply this new approach to understand the interactions between plant and bacteria.
Agtuca’s research is a long way from her first experiences with plants. She still remembers the moment she found her plants in her own garden died. She was less than 10 years old, yet devoted to taking care of her plants with water and fertilizers.
“I was really sad. I could not get my tomatoes, peppers and eggplants to live.…That makes me think that I want to answer why they didn’t grow,” Agtuca said.
More than ever, her future is helping her answer those question for herself.
Gary Stacey is a Bond LSC investigator and MU curators’ professor of plant science and MSMC endowed professor of soybean biotechnology. Read more here about Stacey lab.
Sven Nelson is a USDA/ARS postdoctoral research scientist at the University of Missouri. Anna Glowinski is a Ph.D. student in the USDA/ARS lab. Jessica Kaiser is a graduate student in strategic communication. Eleni Galata works as the team mentor and she is a Ph.D. student in agricultural and applied economics at MU.
Lloyd Sumner, biochemistry professor and Director of the Metabolomics Center at Bond LSC. | photo by Mary Jane Rogers, Bond LSC
By Mary Jane Rogers | Bond LSC
“#IAmScience because I have an infinite curiosity and we have some powerful toolsets that I am confident will make a difference, not just in plant biochemistry, but in many scientific arenas.”
What change you would like to see in this world because of your research?
“I’m a technology junkie at heart. We are developing tools that can potentially advance many areas, and not just my own personal research program. I want to continue to build upon these tools and also apply them in a meaningful manner. On the plant side, I want to discover and characterize many new biochemical pathways, and use this information to make stronger, healthier and more productive plants. I also want to apply these cutting-edge tools to an ever expanding set of problems; i.e. cancer, veterinary medicine, nutrition, etc. I’m confident that every day when I get up, by the end of that day, week or month that we are making that difference.” -Lloyd Sumner
Scott Peck, a biochemistry professor at Bond LSC. | photo by Mary Jane Rogers, Bond LSC
By Mary Jane Rogers | Bond LSC
“#IAmScience because I want to discover. I want to ‘see’ – by understanding – things that others haven’t ‘seen’ before.”
Every day we make decisions based off on what we encounter in the environment. Plants do the same thing. Scott Peck, a Chicago-area native, is a biochemist who studies how plants translate information they receive about the environment (such as changes in light and temperature) into their own chemical “decisions”, also known as signal transduction. For him, it’s about making biology into a puzzle. Put the right pieces together, and you find ways to create more resistant crops or more effective antibiotics. With today’s technology and Peck’s passion for plant communication, anything could be possible.
Debbie Allen, the Coordinator of Graduate Initatives at Bond LSC. | photo by Mary Jane Rogers, Bond LSC
By Mary Jane Rogers | Bond LSC
“#IAmScience because during their journey all graduate students deserve expertise, care and advocacy from graduate coordinators.”
As Coordinator of Graduate Life Science Initiatives, Debbie Allen facilitates several activities supporting graduate recruitment, training, mentoring and career services. In other words, she’s been the “mama bear” to many life sciences graduate students over the years, and is passionate about student advocacy. To Debbie, while understanding the hard science her students study is important, supporting those students through their challenges and triumphs, and guiding them closer to their goals motivates her every day.
Vinit Shanbhag mixes the CRISPR plasmid DNA with cells. The lab will test whether the gene of interest has been knocked out of the cells later. | photo by Jinghong Chen, Bond LSC
Jinghong Chen | Bond Life Sciences Center
It might be strange to say, but in a way the Australian soil led scientist Michael Petris to where he is now.
In certain areas of Australia, soils suffer from extremely low level of copper bioavailability, resulting in poor growth and neurological problems on sheep.
Petris, a Bond LSC investigator and professor of biochemistry who was born in Australia, now spends his time studying how copper, an essential mineral in human body, works in cells to build and maintain essential functions.
Recently published work from his lab focuses on how the ATP7A protein, one of the major proteins, cycles within the cell.
“Copper is solely acquired from diet. The absorption of copper from the intestine in the blood needs ATP7A,” Vinit Shanbhag, a Ph.D. biochemistry student at Petris’ lab and an author of the study, said. “It transports copper to different copper dependent enzymes and exports free copper from the cell to the outside.”
After exporting copper at the cell membrane, ATP7A needs to come back to its steady-state location within the Golgi apparatus of cells – via a process called retrograde trafficking. But one question baffled scientists: what are the key elements that lead ATP7A coming back?
Back in the late 90s, Petris discovered the importance of one single di-leucine in retrograde trafficking of ATP7A. For those of you wondering, leucine is an amino acid that forms the building blocks of proteins like ATP7A, while di-leucine consists of two of them connected via a peptide bond.
His team wished to identify other signals for retrograde trafficking, but one technical hurdle stood in the way— the ATP7A gene is unstable when grown in bacterial plasmids, the traditional way of amplifying genes in the lab.
Commercial DNA synthesis was the answer. This method could create artificial genes in the laboratory.
“We reasoned that if we introduced enough silent mutations into a DNA sequence, we could avoid or change the region of instability in the native sequence without affecting the encoded protein,” Petris said.
To stabilize the gene, they changed more than 1,000 nucleotides within a 3,000 nucleotides segment, and thus solving the problem of instability of the ATP7A gene. In doing so, they subsequently found that in fact multiple di-leucines that are required for retrograde trafficking of ATP7A. This approach could be used by other laboratories whose gene of interest is also unstable.
An overlooked mineral
“If you ask [people], is it important to understand iron nutrition? Is it important to understand calcium nutrition? Most people would say of course! … But, perhaps you would not get the same answer for copper, despite the fact there is a little dispute that copper is important,” Petris said.
As an essential micronutrient, copper performs central functions to develop and maintain human skin, bones, brains and other organs.
“If you don’t have enough copper in your body, you cannot use oxygen to make energy,” Petris said. “If you don’t have copper, you would not survive.”
Pregnant women who carry a mutated ATP7A gene on their X chromosome can pass it on to their children in the form of Menkes disease.
Menkes disease is a genetic disorder that results in poor uptake and distribution of copper to cells. The incidence of this disease is estimated to be one in 100,000 newborns, according to U.S. National Library of Medicine.
Infants with Menkes disease typically begin to develop symptoms during infancy and rarely live past the first few years of life. Abnormally high accumulation of copper in kidneys and low-level accumulation in the liver and brain, cause visible symptoms like sparse hair, loose skin and failure to grow.
Despite copper’s importance, it also can be a potentially toxic nutrient.
“Copper deficiency can be a problem but too much copper is also a problem. There should be a balance,” Shanbhag explained.
The liver normally stores excessive copper and excretes it into bile to release it out of the body. Yet people with genetic disorders that preventing copper excretion might suffer Wilson’s disease, leading to life-threatening organ damage.
Shanbhag said people with Wilson’s disease accumulate toxic amounts of copper in liver and other organs, causing Kayser–Fleischer rings that encircle the pigmented regions of the eye, a hue caused by copper deposits in the cornea.
Its clinical consequences differ from chornic liver failure to neurological sysmptoms like tremors, dystonia, ataxia and cognitive deteriortation.
About one in 30,000 people have Wilson disease, according to National Institute of Diabetes and Digestive and Kidney Diseases.
Starving tumors
Vinit Shanbhag mixes the CRISPR DNA with mammalian cells to specifically delete a gene in these cells in lab hood. | photo by Jinghong Chen, Bond LSC
In 2013, Petris’ lab published the first direct evidence suggesting ATP7A is essential for the dietary absorption of copper. Since then they have dug deeper into this copper transporter, and his lab now sets their sights on a greater enemy of human health — cancer.
Tumor growth requires access to large amounts of nutrients. Without an adequate supply of oxygen and nutrients, tumors fail to grow and survive. Scientists have identified that by preventing access to nutrients—for example by blocking the growth of new blood vessels—they could starve the tumor of nutrients.
Copper is a key nutrient for tumor growth. With the new-introduced system CRISPR-Cas9 — a genome editing tool to knock out specfic genes — his lab has explored how to exploit understanding of copper metabolic pathways to withhold copper from cancer cells.
“Copper starvation might be a good approach as an anti-cancer strategy,” Petris said.
Weapon of the immune system
Michael Petris, a professor of biochemistry at MU, stands with his lab. From left to right: Vinit Shanbhag, Nikita Gudekar, Michael Petris, Kimberly Jasmer-McDonald, Aslam Khan. | photo by Jinghong Chen, Bond LSC
Currently, four members study in Petris’ lab to tackle the relationship between copper and various diseases. Petris plans to expand his research to another area: the role of copper in innate immunity against bacterial pathogens.
This is the topic of Petris’ next grant. Nutritional immunity, which describes how the mammalian host withholds nutrients from the invading bacteria during infection, is very well-described for iron and zinc.
Yet copper performs differently.
During infection, the level of copper in blood actually goes up instead of going down. The immune system concentrates copper at sites of infection and within regions where the bacteria are engulfed.
“We speculate that copper is being used as weapon by the host to kill the bacteria,” Petris said. “That is the area we are trying to develop further.”
What if you could have pork without the pig? Nicholas Genovese’s cultured meat could provide a more environmentally friendly meat
This screenshot of a supplemental video included in Genovese’s study shows cells contracting in response to a neurotransmitter. | photo courtesy of the Nicholas Genovese
By Eleanor C. Hasenbeck | MU Bond Life Sciences Center
Scientists are one step closer to that reality. For the first time, researchers in the Roberts’ lab at Bond Life Sciences Center at MU were able to create a framework to make pig skeletal muscle cells from cell cultures.
In vitro meat, also known as cultured meat or cell-cultured meat, is made up of muscle cells created from cultured stem cells.
As a visiting scholar at the University of Missouri, Nicholas Genovese mapped out pathways to successfully create the first batch of in vitro pork. Genovese also said it was the first time it was done without an animal serum, a growth agent made from animal blood.
According to Genovese, his research in the Roberts Lab was also the first time the field of in vitro meats was studied at an American university.
“I feel it’s a very meaningful way to create more environmentally sustainable meats, which is going to use fewer resources, with fewer environmental impacts and reduce need for animal suffering and slaughter while providing meats for everyone who loves meat,” Genovese said.
The research could have environmental impacts. According to the United Nation’s Food and Agriculture Organization, livestock produce 14.5 percent of all human-produced greenhouse gas emissions. Livestock grazing and feed production takes up 59 percent of the earth’s un-iced landscape. Cultured meat takes up only as much land as the laboratory or kitchen (or carnery, the term some members of the industry have coined for their facilities) it is produced in. It uses energy more efficiently. According to Genovese, three calories of energy can produce one calorie of consumable meat. The conversion factor in meat produced by an animal is much higher. According to the FAO, a cow must consume 11 calories to produce one calorie of beef for human consumption.
And while Michael Roberts, the lab’s principal investigator, is skeptical of how successful in vitro meat will be, he said the results could yield other benefits. Researchers might be able to use a similar technique as they used to create skeletal muscle tissue to make cardiac muscle tissue. Pork muscles are anatomically similar to a human’s and can be used to model treatments for regenerative muscle therapies, like replacing tissue damaged by injury or heart attacks.
“I was interested in using these cells to show that we could differentiate them into a tissue. It’d been done with human and mouse, but we’re not going to eat human and mouse,” Roberts said. “The pig is so similar in many respects to humans, that if you’re going to test out technology and regenerative medicine, the pig is really an ideal animal for doing this, particularly for heart muscle,” he added.
While you won’t find in vitro meat in the supermarket just yet, Genovese and others are working toward making cultured meats a reality for the masses. Right now, producing in vitro meat is too costly to make it economically viable. Meat is produced in small batches, and the technology needed to mass-produce it just isn’t there yet. Genovese recently co-founded the company Memphis Meats, where he now serves as Chief Scientific Officer. The company premiered the first in vitro meatball last year, at the hefty price tag of $18,000.
“We are rapidly accelerating our process towards developments of technology that we hope will make cultured meats accessible to everyone within the not-so-distant future,” Genovese said.
Nicholas Genovese was a member of the Roberts lab in Bond LSC from 2012 to 2016. The study “Enhanced Development of Skeletal Myotubes from Porcine Induced Pluripotent Stem Cells” was recently published by the journal Scientific Reports in February 2017.
